These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 3449807

  • 1. Hypolipemic and potential antiatherosclerotic properties of diprophyllinyl-4-benzyloxybenzoate.
    Wójcicki J, Samochowiec L, Dadej R, Jaworska M, Gawrońska-Szklarz B, Kownacka A, Ryshenkov V, Chistyakova A, Acsenova N.
    Pol J Pharmacol Pharm; 1987; 39(4):343-51. PubMed ID: 3449807
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Anti-atherosclerotic efficacy of quercetin and sodium phenylbutyrate in rabbits].
    Mokrzycki K.
    Ann Acad Med Stetin; 2000; 46():189-200. PubMed ID: 11712304
    [Abstract] [Full Text] [Related]

  • 5. Hypolipidaemic and antiatherosclerotic effects of plumbagin in rabbits.
    Sharma I, Gusain D, Dixit VP.
    Indian J Physiol Pharmacol; 1991 Jan; 35(1):10-4. PubMed ID: 1917004
    [Abstract] [Full Text] [Related]

  • 6. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.
    Hu MY, Li YL, Jiang CH, Liu ZQ, Qu SL, Huang YM.
    Nutrition; 2008 Oct; 24(10):1030-8. PubMed ID: 18585898
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Hypolipidemic properties of triterpenoids].
    Vasilenko IuK, Lisevitskaia LI, Frolova LM, Parfent'eva EP, Skul'te IV.
    Farmakol Toksikol; 1982 Oct; 45(5):66-70. PubMed ID: 7140959
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The antiatherosclerotic effects of a polysaccharide from raw animal stock].
    Rasulov MM, Velikaia MV, Zabozlaev AG, Kuznetsov IG, Voronkov MG.
    Biull Eksp Biol Med; 1993 Nov; 116(11):460-2. PubMed ID: 7508765
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A search for a model of experimental atherosclerosis: comparative studies in rabbits, guinea pigs and rats.
    Wójcicki J, Samochowiec L, Jaworska M, Hinek A.
    Pol J Pharmacol Pharm; 1985 Nov; 37(1):11-21. PubMed ID: 4034437
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits.
    Xing WW, Wu JZ, Jia M, Du J, Zhang H, Qin LP.
    Biomed Pharmacother; 2009 Aug; 63(7):457-62. PubMed ID: 18657948
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits.
    Lee CH, Jeong TS, Choi YK, Hyun BH, Oh GT, Kim EH, Kim JR, Han JI, Bok SH.
    Biochem Biophys Res Commun; 2001 Jun 15; 284(3):681-8. PubMed ID: 11396955
    [Abstract] [Full Text] [Related]

  • 19. Species-related variations in lipoprotein metabolism: the impact of FER(HDL) on susceptibility to atherogenesis.
    Green TJ, Moghadasian MH.
    Life Sci; 2004 Mar 26; 74(19):2441-9. PubMed ID: 14998721
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.